Subscribe to Our Digest
The collaboration pairs Mimulus’s molecular architecture with GenScript’s massive synthesis scale to liberate critical grid power for AI compute and launch the “Forever Archive” for enterprise data permanence.
Mimulus Corp, the pioneer in Molecular Archive Technology™, and GenScript Biotech Corporation, the world’s leading provider of CMOS-based DNA synthesis technologies, today announced a multi-year, milestone-based strategic collaboration to industrialize DNA-based data storage.
As global cold archive data volumes race toward 200 zettabytes by the end of the decade, the build-out of global AI infrastructure has hit a physical wall where two critical bottlenecks are colliding. First, power availability — not GPU compute — has become the ultimate limit on AI expansion. Second, legacy cold archives built on magnetic tape and spinning disks continue to drain critical grid capacity, plagued by costly forced migrations and data corruption. This partnership aims to solve both issues simultaneously by leveraging Mimulus’s “zero-watt,” off-grid Molecular Archive Technology™ platform to architect and scale a fundamentally new infrastructure for the cold archive data storage tier.
“When a new category emerges, the winners are built on infrastructure,” said Sherry Shao, Rotating CEO of GenScript Biotech Corporation. “At GenScript, we believe in Scripting Possibilities—turning what was once theoretical into scalable reality. DNA-based data storage will only become a viable real-world infrastructure when synthesis can be delivered at extraordinary throughput, quality, and cost. With Mimulus, we are building that industrial foundation to transform molecular storage from being ‘scientific promise’ into ‘global reality’.”
Under the agreement, GenScript will industrialize high-throughput DNA synthesis at scale to enable the mass production of Mimulus’s Glacier Data Storage Cards™. The Glacier Card stores data permanently on a credit-card-sized device that requires no power, no cooling, and no ongoing maintenance—and the data never degrades.
Under the agreement, Mimulus has secured an option to an exclusive license to certain GenScript intellectual property in the field of digital DNA data storage, subject to defined milestones and terms. Representing the most advanced archival technology currently in development, the Mimulus architecture demands a medium capable of incredible density and uncompromised durability. To meet these rigorous specifications, GenScript will leverage its highly validated manufacturing platform—capable of synthesizing millions of oligonucleotides in parallel—delivering the scale and reproducibility required to make molecular data storage commercially viable.
The partnership scales the deployment of Mimulus’s Glacier Data Storage Cards™ to enable:
“Treating archival data as a multi-megawatt electrical load is a thermodynamic dead-end for the AI industry,” said Todd R. Nelson, Ph.D., Founder and Chairman of Mimulus Corp. “When a single zero-watt Glacier Card can replace hundreds of thousands of power-hungry hard drives, you completely erase the physical footprint, drop the electrical draw to zero, and eliminate the need for massive cooling infrastructure. With GenScript’s manufacturing scale, we are liquidating a massive operational liability—decarbonizing the data center and giving hyperscalers the exact megawatts they need for AI compute, all while delivering absolute data permanence to the enterprise.”
To support near-term enterprise pilots and future commercialization, the teams are co-developing an integrated manufacturing pipeline alongside industry-standard S3 API compatibility, ensuring seamless integration for data center operators as Mimulus targets full hyperscale production by the end of the decade.
More information about Mimulus’s Glacier Data Storage Cards